| Dr Thomas R Komp, DPM | |
|
1800 Lawrence Dr, De Pere, WI 54115-9108 | |
| (920) 983-3220 | |
| (920) 983-3226 |
| Full Name | Dr Thomas R Komp |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 41 Years |
| Location | 1800 Lawrence Dr, De Pere, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265424162 | NPI | - | NPPES |
| 41732500 | Other | WI | MEDICAID DME |
| 43205900 | Medicaid | WI | |
| 0256660001 | Other | WI | MEDICARE DME |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | 534-025 (Wisconsin) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bellin Memorial Hospital Inc | 8820900749 | 513 |
News Archive
A team of scientists from Italy has recently conducted a study to investigate the incidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among students attending Italian schools after reopening after COVID-19 lockdown. The findings reveal that the transmission of SARS-CoV-2 is low among younger students. The study is published on the medRxiv preprint server.
Biotage, a leading supplier of tools and technology for analytical and medicinal chemistry, announced the addition of ChemMatrix resins to its extensive offering of peptide synthesis and purification products.
Scientists at the University of California, San Diego School of Medicine have described for the first time a key inhibitory role for the IL-1 signaling pathway in the human innate immune system, providing novel insights into human inflammatory bowel disease (IBD) and potential new treatments.
People who get the shingles vaccine may have a lower risk of being diagnosed and hospitalized with coronavirus disease 2019 (COVID-19), according to a new medRxiv* preprint study. In about 150,000 people over the age of 50, vaccination for shingles was associated with a 32% reduced risk of severe COVID-19 infection.
› Verified 5 days ago
| Provider Name | Bellin Memorial Hospital Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1609838473 PECOS PAC ID: 8820900749 Enrollment ID: O20031121000089 |
News Archive
A team of scientists from Italy has recently conducted a study to investigate the incidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among students attending Italian schools after reopening after COVID-19 lockdown. The findings reveal that the transmission of SARS-CoV-2 is low among younger students. The study is published on the medRxiv preprint server.
Biotage, a leading supplier of tools and technology for analytical and medicinal chemistry, announced the addition of ChemMatrix resins to its extensive offering of peptide synthesis and purification products.
Scientists at the University of California, San Diego School of Medicine have described for the first time a key inhibitory role for the IL-1 signaling pathway in the human innate immune system, providing novel insights into human inflammatory bowel disease (IBD) and potential new treatments.
People who get the shingles vaccine may have a lower risk of being diagnosed and hospitalized with coronavirus disease 2019 (COVID-19), according to a new medRxiv* preprint study. In about 150,000 people over the age of 50, vaccination for shingles was associated with a 32% reduced risk of severe COVID-19 infection.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas R Komp, DPM Po Box 22487, Green Bay, WI 54305-2487 Ph: (920) 445-7210 | Dr Thomas R Komp, DPM 1800 Lawrence Dr, De Pere, WI 54115-9108 Ph: (920) 983-3220 |
News Archive
A team of scientists from Italy has recently conducted a study to investigate the incidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among students attending Italian schools after reopening after COVID-19 lockdown. The findings reveal that the transmission of SARS-CoV-2 is low among younger students. The study is published on the medRxiv preprint server.
Biotage, a leading supplier of tools and technology for analytical and medicinal chemistry, announced the addition of ChemMatrix resins to its extensive offering of peptide synthesis and purification products.
Scientists at the University of California, San Diego School of Medicine have described for the first time a key inhibitory role for the IL-1 signaling pathway in the human innate immune system, providing novel insights into human inflammatory bowel disease (IBD) and potential new treatments.
People who get the shingles vaccine may have a lower risk of being diagnosed and hospitalized with coronavirus disease 2019 (COVID-19), according to a new medRxiv* preprint study. In about 150,000 people over the age of 50, vaccination for shingles was associated with a 32% reduced risk of severe COVID-19 infection.
› Verified 5 days ago